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ABSTRACT
The principal gamma-ray-emitting radioisotopes produced in the body
of astronauts by cosmic-ray bombardment which have half-lives long enough
to be useful for radiation dose evaluation are 7Be, 22Na, and 24Na. The
sodium isotopes were measured in the preflight and postflight urine and
feces, and those feces specimens collected during the manned Apollo
missions, by analysis of the urine salts and the raw feces in large
crystal multidimensional gamma-ray spectrometers. The 7Be was chemically
separated, and its concentration measured in an all NaI(T1), anticoincidence
shielded, scintillation well crystal.
The overall sensitivity of the experiment was reduced by almost'all
variables such as low concentrations of excreted cosmogenic radionuclides,
high concentrations of injected radionuclides, low sample sizes, long
delay periods before analysis, and uncertain excretion rates. The
astronaut, radiation dose in millirads, as determined by this technique,
for the Apollo 7, 8, 9, 10, ll, 12, and 13 missions was 330, 160, <315,
870 _ 550, 31, ll0, and <250 respectively. In view of these limitations
this technique would be best applied to cases of unusually high exposures,
such as that encountered from solar flares.
INTRODUCTION
With the advent of space flight, it has
become necessary to determine the radiation
dose to man from exposure to the galactic, Van
Allen, and solar flare particles. The high-
energy galactic portion of the spectrum is
fairly constant and has a relatively low inten-
sity. The high i_tensity Van Allen radiation
is of medium energy and localized in space.
However, the solar radiation is not so predic-
table, and the flux and energy of particles
from the sun can vary tremendously depending on
solar activity. Since high levels of radia-
tion exposure are possible, radiation dosimetry
which will properly define radiation exposures
is essential in space research programs. Dos-
imetry methods employed thus far, such as nuc-
lear emulsion films, thermoluminescent dosim-
eters, and ionization gauges provide very use-
ful indirect methods for estimating radiation
dose but are subject to limitations. They
measure only a surface exposure at a specific
point(s) in the spacecraft or on the astronaut's
body rather than an integral whole body expos-
ure, and they have a limited sensitivity to
large variations in particle energy. Some of
the inherent limitations of these external dos-
imeters are avoided by using the induced radio-
(a)
activity in the body of an astronaut as a meas-
ure of his radiation exposure. During a space
flight, radionuclides are produced throughout
the entire body of an astronaut, and the pro-
duction rates are related directly to the cosmic
particle flux within the body. The absolute and
relative amounts of the various radionuclides
bear a direct relationship to the intensity and
energy spectrum of the particles which are doing
the biological damage.
The radiation dose received from the cosmic
particles can be determined _rom the quantities
of induced radionuclides _I-_). The amounts of
these induced activities can be determined by
direct measurement, i.e., whole body counting of
the astronaut, or by indirect measurement, such
as counting the radionuclides excreted in the
feces and urine. The latter approach was used
for evaluation of radiation activation during
the course of the manned Apollo missions.
The principal gamma-ray-emitting radioiso-
topes produced in the body by cosmic-ray bom-
bardment are 7Be (t_-=53 da_), IIC (_=20.5 min),
13N (_=9.96 min),_2Na (t_=2.60 _r), and 2_Na
(t½=lS.0 hr). The primary mode of production
of 7Be and IIc is the spallation of carbon,
nitrogen, and oxygen in the body. The 13N comes
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principally fromthespallationof nitrogen
andoxygen,the22Nafromthe spallationof
sodium,phosphorus,andcalcium,andthe 24Na
fromthe neutronactivationof naturalsodium.
Of these,IIC and13Naretoo short-livedto
bemeasuredby anymethodotherthana direct
determination,andthis direct countingwould
haveto bedoneassoonaspossibleafter re-
covery. Thisis unfortunate,sincethese
radioisotopesareproducedin the largest abun-
dance.Theradionuclides7Be,22Na,and24Na
are,however,sufficiently long-livedto facil-
itate their usein makingdoseestimatesfrom
measurementof heir quantitiesin urineand
fecal samples.
Otheradioisotopeswerealsoexpectedto
bepresentin thebioassaysamples.In addi-
tion to theaforementionedcosmogenicradio-
nuclides,measurementsof naturallypresent
40K;normallyoccurring7Be,22Na,and13?Cs;
and51Orand59Fewhichwereinjectedfor med-
ical studieswerealsomade.Anotheradio-
isotope,60Co,wasdetectedandquantitatively
measuredin someof the specimens.Corrections
to the cosmogenic7Beand22Namustbemadeto
accountfor the_quantitiesof theseradioiso-
topesnormallyoccurringin thebodybecauseof
fallout, foodintake,andotheringestionpro-
cesses.Thequantitiesof thenaturallyoccur-
ing _0Kandthe injected51Crand59Fein the
bioassaysamplescouldserveasbiological
tracersof variouschangesof metabolicpro-
cessesduringthe courseof amission.
In previousstudies,inducedradioactivity
to radiationdoserelationshipshavebeenes-
tablishedfor theradionuclides7Be,22Na,and
24Nasa functionof.energyfor protonbombard-
mentof muscletissue(2). Fromtheserelation-
shipsandfromtheratios in whichtheseradio-
nuclidesareproduced,the "effectiveproton
energy"of cosmicradiationincidentonanas-
tronautcanbedetermined.Thisallowsthe
direct estimationof thewholebodyradiation
exposurereceivedbyastronautsfrommeasure-
mentsof theradionuclidesproducedin theirbodies.
EXPERIMENTAL
Preflight and postflight urine and feces
and those feces specimens collected in flight
were analyzed. Due to the quarantine period
following lunar landing missions, all samples
were not immediately available for analyses,
thus allowing the short-lived radionuclides to
decay. The urine specimens which were of
small volume were solidified prior to analy-
sis by the addition of caSoh to 25 ml or less
of the raw urine in order to form a standard
counting geometry. Any samples of initial
volume greater than 25 ml were treated by re-
peatedly boiling to dryness with nitric acid
to destroy the organic matter present. The re-
maining salts were counted in large crystal
multidimensional gamma-ray spectrometers (5-7)
for determination of 22Na, 24Na, 40K, 51Cr,
59Fe, 60Co, and 137Cs. The salts were then
redissolved in a weak HCf solution and diluted
to known volume. An aliquot of this solution
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was taken for neutron activation analysis to
determine the concentrations of stable elements
in the sample. The remainder of the solution
was reduced in volume to approximately 15 ml
and transferred to a 100 ml polyethylene cen-
trifuge tube. Approximately 5 mg of Be ++ car-
rier and 20 mg of Fe +++ carrier were added,
and the solution was neutralized with concen-
trated NH40H. After centrifugation the super-
natant solution was discarded. Thirty-five ml
of 3 N Na0H were added to the remaining pre-
cipitate and stirred vigorously until well
mixed. After centrifugation the supernatant
liquid was transferred to a clear centrifuge
tube, saturated with NH4CI , and heated in a
water bath. If necessary, additional NH4CI
was added until a Be(0H)2 precipitate settled
from the solution. The solution was then cen-
trifuged, and the supernatant fraction was
discarded. The resulting quantitative precip-
itate containing the 7Be activity was counted
in an all NaI(TI) anticoincidence shielded,
7-inch diameter scintillation well crystal in
the absence of all interfering activities. This
was necessary in order to measure the rela-
tively small quantities of 7Be present.
Fecal samples were thoroughly mixed in
their collection bags to ensure homogeneity of
the specimens. A small corner was cut off each
bag and aliquots were extruded into standard
counting geometry containers for measurements
on multidimensional gamma-ray spectrometers to
measure the radioisotopes 22Na, 40K, 51Cr, 59Fe,
60Co, and iS7Cs. Separate aliquots were wet
ashed with nitric acid and hydrogen peroxide
to destroy the organic matter present. The re-
sulting salts were dissolved in dilute nitric
acid, and the same procedure as above was fol-
lowed for separation of the 7Be activity.
A luminous material composed of 147pm
microspheres mixed with a scintillator is used
extensively in the spacecraft in acrylic switch
tips and sighting figures used in docking man-
euvers. Because of the high rejection rate of
switch tips caused by promethium leaks, there
is some concern about the possible presence of
147pm in the weightless space capsule environ-
ment. For the later missions, approximately i0
mg of mixed rare earths were added to the feces
prior to wet ashing. These were to serve as
carriers for IW7pm, which could possibly have
been ingested by the crew members. This rare
earth fraction was separated from the beryllium
fraction after the initial NH40H precipitation
by dissolving the precipitate in approximately
8 ml of 3M HC1 and adding 2 ml of 49 percent HF.
Centrifugation separated the rare earth precip-
itate from the beryllium in the supernatant so-
lution. The rare earth fraction was then dis-
solved in two parts concentrated HN03 and three
parts saturated boric acid solution and reprecip-
itated with NH40H. After centrifugation and de-
cantation, the precipitate was dissolved in di-
lute HC1; and saturated oxalic acid solution was
added to precipitate the rare earth oxalates.
The solution was centrifuged; the supernatant so-
lution was decanted; and the quantitative precip-
itate was washed with alcohol, transferred to a
1-inch diameter stainless steel dish and counted
in an end window, gas flow beta counter for the
measurement of 147pm.
RESULTS
Theresultsof the individualdeterminations
aregivenin TablesI throughIV. All datahave
beennormaliledto a gramof feces,amilliliter
of urine, or a gramof the respectivestable
elementasdeterminedby a techniqge,ofinstru-
mentalneutronactivationanalysisLS) All data
have been decay corrected to the time of splash-
down of each respective mission. The results
of all the radionuelide measurements in the
excreta are given in the tables although only
the concentrations of the cosmogenic radionuelides
7Be, 22Na, and 24Na are of importance for the
subject matter of this communication. The
various samples in the tables are listed by the
letters A, B, and C or LMP, CMP, and CDR to
identify an individual astronaut. Those samples
listed by numbers are unidentified and arbitra-
rily coded. The collection time for each speci-
men is given as Pre-, In-, or Post-flight unless
more detail is known, in which case a number
refers to elapsed time into the mission in hours,
the letter F followed by a number indicates that
number of days prior to flight, post+0 refers
to the first voiding after splashdown, post+l
is the first 2h hour collection after splashdown
and day 2 is the following day after splashdown.
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The average values of the cosmogenic radio-
nuclide concentrations in each basic flight per-
iod are summarized in Table V according to the
various methods of normalization. The increase
in the activities from preflight to inflight
and postflight periods should be indicative of
the exposure to cosmic radiation. The concentra-
tions of each radionuclide increase rather
regularly for the Apollo T mission regardless of
the method of normalization. However, the fecal
data for the Apollo 8 mission are quite irregular,
with only the urine data demonstrating increases
in the eosmogenic radionuclides. The Apollo 9
and 13 missions show increases in the 7Be concen-
tration in the urine but demonstrate decreases
in the 22Na concentrations while the reverse is
true for Apollo ll. Regular increases are
shown for Apollo lO and 12.
The increases in cosmogenic radioactivity
from preflight levels to those after exposure to
the space environment are almost certainly due
to cosmic particle activation. Equating the
magnitude of the increase with the radiation dose
delivered by the particles is still fairly
difficult, particularly when the dose is quite
small as has been the case on all manned Apollo
missions thus far. Concentrations normalized to
the unit mass or volume of excreta are subject
to variation in the biological dilution of the
specimen. Concentrations normalized to the unit
mass of stable element in the feces are also
subject to variations in the quantities of
unmetabolized elements passing through the
gastrointestinal tract. 0nly the quantities of
radionuclides in the urine normalized to the
amount of stable element present can be ex-
pected to be reasonably representative of the
specific activity in the whole bcdy since the
urine contains only metabolized material.
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Indeed, it is necessary to make some assump-
tions regarding the percentages of the body bur-
den of an element excreted in the feces or
urine, the relative dilution factors of feces
and urine, and the "contamination" of feces by
unmetabolized elements in order to compare the
data with the experiment@l results for proton
irradiated muscle tissue _I, 2) proton irradiated(3)
radiotherapy patients • , and neutron irradiated
radiotherapy patients . In this manner, the
average effective proton energy incident on the
astronauts and the radiation dose received by
them can be estimated. The details of these
calculations will be omitted here since they are
given elsewhere (9-12) . The results indicate an
average effective proton energy of 38-40 MeV
incident on the Apollo 7 mission astronauts and
<38 MeV on the Apollo 8 mission astronauts.
Radiation doses of h80 + 310, <B15, 870 + 550,
<_80, and <250 millirad_ for the Apollo _, 9,
10, 12, and 13 missions respectively are calcu-
lated.
Since the specific activity of the cosmo-
genic radionuelides in the urine should be a
more accurate representation of the whole body
burden of induced radioactivity, the specific
activity of the 22Na in the postflight urine of
astronauts is compared to the specific activity
of 22Na in the urine of radiotherapy patients
who have received a known radiation dose. This
comparison leads to estimated cosmic radiation
doses received by the astronauts on the Apollo 7,
8, ll, and 12 missions of 330, 160, 31, and llO
millirads respectively. It should be pointed out
here that the uncertainty of the data given in
Table V, and hence of these results, is quite
large in some instances.
DISCUSSION
In principle the relationships between in-
duced activity and radiation dose are straight-
forward. The probability for production of a
certain isotope in the body of an astronaut is
basically a function of the energy of the proton.
Similarly, the radiation dose from a cosmic proton
is also a function of its energy, and therefore,
the induced activity is logically related to the
radiation dose. Such relationships have been
empirically deSermined for several different
situations \I-4#, and it remains only to measure
the quantities of induced radionuclides in a
particle irradiated person to determine the dose
he received.
In practice, however, the procedure is not
quite as simple as that just described. A cali-
brated whole-body counter is required to deter-
mine the quantities of induced radionuclides,
and a high sensitivity-low background instrument
would be required to measure the small quantities
of radionuclides induced by the low levels of
cosmic radiation encountered on a normal space
flight. In lieu of the availability of a suitable
whole-body counter, an indirect approach such as
that used in this work can be applied. The prin-
cipal limitations to this method have already
been touched upon above. Only a small and
uncertain fraction of the induced activity is
eliminated in the excreta. Thus only the
ACTIVITY
7Be/g Feces
7Be/g Feces
7Be/g Feces
22Na/g Feces
22Na/g Feces
22Na/g Feces
22Na/g Na in
Feces
22Na/g Na in
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7Be/ml Urine
7Be/ml Urine
22Na/ml Urine
22Na/ml Urine
24Na/nLl Urine
22Na/g Na in
Urine
22Na/g Na in
Urine
24Na/g Na in
Urine
TABLE V
AVERAGE RADIONUCLIDE CONCENTRATIONS IN EXCRETA FROM APOLLO ASTRONAUTS
NORMALIZED RADIOACTIVITY IN DISINTEGRATIONS PER MINUTE
FLIGHT
PERIOD APOLLO 7 APOLLO 8
Pre 1.12 3.25
In 1.59 1.78
Post 2.94 2.33
Pre 0.025
In O.OOlh O.0014
Post 0.0026 0.040
In 0.26 0.26
Post 2.8
Pre O.159
Post 0.755 1.20
Pre
Post 0.0038 0.0009
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Pre
Post 3.2 1.6
APOLLO _ APOLLO lO APOLLO ii APOLLO 12 APOLLO 13
1.25 0.36 0.i0 2.79 0.98
0. 015
7.8
0.0007 o.0039
0.O14 0.264 0.233
0.o55 0.077 0.051 0.68
0.0005 0.O004 O.00O3 0.0003 o.oo13
0.0002 0.0009 0.0008 0.0016
O.04
0.17 0.08
0.30 i.i
Post 20
specific activity of an induced radioisotope in
the urine can be extrapolated to the whole body
burden with a reasonable degree of accuracy.
While the efficiency of low-level sample
counters is routinely several orders of magnitude
higher than whole-body counters, the small frac-
tion of the total body activity in any bioassay
sample reduces the sensitivity of a specimen
measurement to the point where it is little
better than that of a whole-body count. " To com-
plicate the situation in this work even further,
there is a large demand for aliquots of post-
flight urine specimens from the astronauts and
typically only 10% or less of a 24-hour collection
has been available for radionuclide concentration
measurements. An additional complication in the
case of non-lunar-landing missions (Apollo 13
excepted) was the injection of radioisotopes into
the astronauts for medical studies. Although
these isotopes were not the same as the cosmo-
genic radionuclides measured, their presence in
the excreta lowered the overall accuracy of the
measurements. Finally, the quarantine require-
ments of the lunar landing missions caused a
delay in the analysis of postflight specimens
which allowed substantial decay of the radio-
nuclides present. These factors all contribute
to the reduced accuracy and sensitivity of the
measurements reported herein. In an effort to
improve the situation, a high sensitivity com-
bination whole-body counter and sample counter
has been proposed which could be rapidly utilized
after a mission (even onboard the recovery vessel)
to make accurate measurements of the whole body
burden of radionuclides in the astronauts. The
combination of direct measurement of whole body
burdens of radionuelides and the early measure-
ment of relatively large quantities of excreta
should make much more accurate dose estimates
possible.
This technique for measurement of radiation
dose should be perfected during routine space
missions-so that'in the event of an unusually
high exposure, such as might be expected from a
solar flare, an accurate determination of the
radiation dose can be obtained. This situation
would be _nologQus to those nuclear criticality
accidents L13-15) where conventional dosimetry
techniques were saturated and induced radio-
activity was measured to interpret the radiation
dose received by the exposed individuals.
_. •
!./ i'
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